Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Hyperinsulinemic hypoglycemia after gastric bypass surgery: what’s up and what’s down?

Abstract

Obesity is a global public health problem and attempts to treat this condition using life style with and without pharmacological interventions have not been successful in majority of obese individuals. To date, the most effective treatment for obesity is weight loss surgery. One of the most widely used procedures to treat obesity worldwide, Roux-en-Y gastric bypass surgery (RYGB), has shown to induce diabetes remission in addition to significant and sustainable weight loss. As the number of this procedure performed over the last two decades increased, it has become clear that a subgroup of individuals develop postprandial hypoglycemia several years after surgery. This debilitating late complication of RYGB is often associated with loss of consciousness or seizures, and in severe cases, it is only partially responsive to diet modification or other available therapeutic options. The diagnosis is often a challenge resulting in delays in receiving care in the affected individuals. Although the underlying mechanisms are under current investigations, growing evidence suggest that a combination of exaggerated meal-derived nutrient appearance to systemic circulation and altered islet and gut hormone response after eating have a role in pathogenesis of this condition. The goal of this review is to highlight new perspectives regarding this life-threatening complication of RYGB. The etiology, diagnosis, recommendation on how to distinguish from classic dumping and current available treatment based on literature review will be discussed. In addition, physiologic changes after gastric bypass predisposing to hypoglycemia syndrome will be highlighted.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

References

  1. WHO Obesity and overweight fact sheet 311-updated June 2016.

  2. Anderson JW, Konz EC, Frederich RC, Wood CL . Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 2001; 74: 579–584.

    Article  CAS  Google Scholar 

  3. Kraschnewski JL, Boan J, Esposito J, Sherwood NE, Lehman EB, Kephart DK et al. Long-term weight loss maintenance in the United States. Int J Obes (Lond) 2010; 34: 1644–1654.

    Article  CAS  Google Scholar 

  4. Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 2011; 365: 1597–1604.

    Article  CAS  Google Scholar 

  5. Fothergill E, Guo J, Howard L, Kerns JC, Knuth ND, Brychta R et al. Persistent metabolic adaptation 6 years after ‘The Biggest Loser’ competition. Obesity 2016; 24: 1612–1619.

    Article  Google Scholar 

  6. Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ et al. Association of pharmacological treatments for obesity with weight loss and adverse events. JAMA 2016; 315: 2424–2434.

    Article  CAS  Google Scholar 

  7. Mason EE . History of obesity surgery. Surg Obes Relat Dis 2005; 1: 123–125.

    Article  Google Scholar 

  8. Buchwald H, Schone JL . Gastric obesity surgery combined with partial ileal bypass for hypercholesterolemia. Obes Surg 1997; 7: 313–316.

    Article  CAS  Google Scholar 

  9. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248–256.

    Article  Google Scholar 

  10. Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 347: f5934.

    Article  Google Scholar 

  11. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467–484 discussion 84–85.

    PubMed  PubMed Central  Google Scholar 

  12. Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 2005; 48: 2236–2240.

    Article  CAS  Google Scholar 

  13. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Cavell ML, Lloyd RV . Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 2005; 353: 249–254.

    Article  CAS  Google Scholar 

  14. Marsk R, Jonas E, Rasmussen F, Näslund E . Nationwide cohort study of post-gastric bypass hypoglycaemia including 5040 patients undergoing surgery for obesity in 1986–2006 in Sweden. Diabetologia 2010; 53: 2307–2311.

    Article  CAS  Google Scholar 

  15. Kellogg TA, Bantle JP, Leslie DB, Redmond JB, Slusarek B, Swan T et al. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis 2008; 4: 492–499.

    Article  Google Scholar 

  16. Lee CJ, Wood GC, Lazo M, Brown TT, Clark JM, Still C et al. Risk of post-gastric bypass surgery hypoglycemia in nondiabetic individuals: a single center experience. Obesity 2016; 24: 1342–1348.

    Article  CAS  Google Scholar 

  17. Whipple AO, Frantz VK . Adenoma of islet cells with hyperinsulinism: a review. Ann Surg 1935; 101: 1299–1335.

    Article  CAS  Google Scholar 

  18. Towler DA, Havlin CE, Craft S, Cryer P . Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 1993; 42: 1791–1798.

    Article  CAS  Google Scholar 

  19. Lev-Ran A, Anderson RW . The diagnosis of postprandial hypoglycemia. Diabetes 1981; 30: 996–999.

    Article  CAS  Google Scholar 

  20. Salehi M, Gastaldelli A, D’Alessio DA . Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia. J Clin Endocrinol Metab 2014; 99: 2008–2017.

    Article  CAS  Google Scholar 

  21. Jørgensen NB, Jacobsen SH, Dirksen C, Bojsen-Møller KN, Naver L, Hvolris L et al. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance. Am J Physiol Endocrinol Metab 2012; 303: E122–E131.

    Article  Google Scholar 

  22. Salehi M, Gastaldelli A, D’Alessio DA . Evidence from a single individual that increased plasma GLP-1 and GLP-1-stimulated insulin secretion after gastric bypass are independent of foregut exclusion. Diabetologia 2014; 57: 1495–1499.

    Article  Google Scholar 

  23. Roslin M, Damani T, Oren J, Andrews R, Yatco E, Shah P . Abnormal glucose tolerance testing following gastric bypass demonstrates reactive hypoglycemia. Surg Endosc 2011; 25: 1926–1932.

    Article  Google Scholar 

  24. Kefurt R, Langer FB, Schindler K, Shakeri-Leidenmühler S, Ludvik B, Prager G . Hypoglycemia after Roux-En-Y gastric bypass: detection rates of continuous glucose monitoring (CGM) versus mixed meal test. Surg Obes Relat Dis 2015; 11: 564–569.

    Article  Google Scholar 

  25. Van Beek AP, Emous M, Laville M, Tack J . Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management. Obes Rev 2017; 18: 68–85.

    Article  CAS  Google Scholar 

  26. Salehi M, Prigeon RL, D’Alessio DA . Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes 2011; 60: 2308–2314.

    Article  CAS  Google Scholar 

  27. Sigstad H . A clinical diagnostic index in the diagnosis of the dumping syndrome. Acta Med Scand 2009; 188: 479–486.

    Article  Google Scholar 

  28. Hogan MJ, Service FJ, Sharbrough FW, Gerich JE . Oral glucose tolerance test compared with a mixed meal in the diagnosis of reactive hypoglycemia. A caveat on stimulation. Mayo Clin Proc 1983; 58: 491–496.

    CAS  PubMed  Google Scholar 

  29. Charles MA, Hofeldt F, Shackelford A, Waldeck N, Dodson LE, Bunker D et al. Comparison of oral glucose tolerance tests and mixed meals in patients with apparent idiopathic postabsorptive hypoglycemia: absence of hypoglycemia after meals. Diabetes 1981; 30: 465–470.

    Article  CAS  Google Scholar 

  30. Jacobsen SH, Olesen SC, Dirksen C, Jørgensen NB, Bojsen-Møller KN, Kielgast U et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg 2012; 22: 1084–1096.

    Article  CAS  Google Scholar 

  31. Chuang J, Baum L, D’Alessio DA, Salehi M . Glycemic profile assessment using continuous glucose monitoring in patients with and without hypoglyemia after gastric bypass surgery. Diabetes 2012; 61 (Issue Supplement 1).

  32. Mulla CM, Storino A, Yee EU, Lautz D, Sawnhey MS, Moser AJ et al. Insulinoma after bariatric surgery: diagnostic dilemma and therapeutic approaches. Obes Surg 2016; 26: 874–881.

    Article  Google Scholar 

  33. Goh BKP, LLPJ Ooi, Cheow P-C, Tan Y-M, Ong H-S, Chung Y-FA et al. Accurate preoperative localization of insulinomas avoids the need for blind resection and reoperation: analysis of a single institution experience with 17 surgically treated tumors over 19 years. J Gastrointest Surg 2009; 13: 1071–1077.

    Article  Google Scholar 

  34. Reubi JC, Perren A, Rehmann R, Waser B, Christ E, Callery M et al. Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass. Diabetologia 53: 2641–2645.

    Article  CAS  Google Scholar 

  35. Salehi M, Gastaldelli A, D’Alessio DA . Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass. Gastroenterology 2014; 146: 669–680.

    Article  CAS  Google Scholar 

  36. Shah M, Law JH, Micheletto F, Sathananthan M, Dalla Man C, Cobelli C et al. Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes 2014; 63: 483–493.

    Article  CAS  Google Scholar 

  37. Goldfine AB, Mun EC, Devine E, Bernier R, Baz-Hecht M, Jones DB et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 2007; 92: 4678–4685.

    Article  CAS  Google Scholar 

  38. Craig CM, Liu L-F, Deacon CF, Holst JJ, McLaughlin TL . Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia. Diabetologia 2017; 60: 531–540.

    Article  Google Scholar 

  39. Salehi M, Woods SC, D’Alessio DA . Gastric bypass alters both glucose-dependent and glucose-independent regulation of islet hormone secretion. Obesity 2015; 23: 2046–2052.

    Article  CAS  Google Scholar 

  40. Abrahamsson N, Börjesson JL, Sundbom M, Wiklund U, Karlsson FA, Eriksson JW . Gastric bypass reduces symptoms and hormonal responses in hypoglycemia. Diabetes 2016; 65: 2667–2675.

    Article  CAS  Google Scholar 

  41. Patti ME, Li P, Goldfine AB . Insulin response to oral stimuli and glucose effectiveness increased in neuroglycopenia following gastric bypass. Obesity (Silver Spring) 2015; 23: 798–807.

    Article  CAS  Google Scholar 

  42. Botros N, Rijnaarts I, Brandts H, Bleumink G, Janssen I, de Boer H . Effect of carbohydrate restriction in patients with hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. Obes Surg 2014; 24: 1850–1855.

    Article  Google Scholar 

  43. Bantle JP, Laine DC, Castle GW, Thomas JW, Hoogwerf BJ, Goetz FC . Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects. N Engl J Med 1983; 309: 7–12.

    Article  CAS  Google Scholar 

  44. Bantle AE, Wang Q, Bantle JP . Post-gastric bypass hyperinsulinemic hypoglycemia: fructose is a carbohydrate which can be safely consumed. J Clin Endocrinol Metab 2015; 100: 3097–3102.

    Article  CAS  Google Scholar 

  45. Axelsen M, Wesslau C, Lonnroth P, Lenner RA, Smith U . Bedtime uncooked cornstarch supplement prevents nocturnal hypoglycaemia in intensively treated type 1 diabetes subjects. J Intern Med 1999; 245: 229–236.

    Article  CAS  Google Scholar 

  46. Derosa G, Maffioli P . Mini-special issue paper management of diabetic patients with hypoglycemic agents α-glucosidase inhibitors and their use in clinical practice. Arch Med Sci 2012; 5: 899–906.

    Article  Google Scholar 

  47. Valderas JP, Ahuad J, Rubio L, Escalona M, Pollak F, Maiz A . Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels. Obes Surg 2012; 22: 582–586.

    Article  Google Scholar 

  48. Jenkins DJ, Taylor RH, Goff DV, Fielden H, Misiewicz JJ, Sarson DL et al. Scope and specificity of acarbose in slowing carbohydrate absorption in man. Diabetes 1981; 30: 951–954.

    Article  CAS  Google Scholar 

  49. Vezzosi D, Bennet A, Rochaix P, Courbon F, Selves J, Pradere B et al. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. Eur J Endocrinol 2005; 152: 757–767.

    Article  CAS  Google Scholar 

  50. Deloose E, Bisschops R, Holvoet L, Arts J, De Wulf D, Caenepeel P et al. A pilot study of the effects of the somatostatin analog pasireotide in postoperative dumping syndrome. Neurogastroenterol Motil 2014; 26: 803–809.

    Article  CAS  Google Scholar 

  51. Myint KS, Greenfield JR, Farooqi IS, Henning E, Holst JJ, Finer N . Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: the pathophysiological role of GLP1 and its response to a somatostatin analogue. Eur J Endocrinol 2012; 166: 951–955.

    Article  CAS  Google Scholar 

  52. Spanakis E, Gragnoli C . Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia. Obes Surg 2009; 19: 1333–1334.

    Article  Google Scholar 

  53. Gonzalez-Gonzalez A, Delgado M, Fraga-Fuentes MD, Singh K, Patel A, Meacham J . Use of diazoxide in management of severe postprandial hypoglycemia in patient after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2010; 9: e18–e19.

    Article  Google Scholar 

  54. Van Boekel G, Loves S, van Sorge A, Ruinemans-Koerts J, Rijnders T, de Boer H . Weight loss in obese men by caloric restriction and high-dose diazoxide–mediated insulin suppression. Diabetes, Obes Metab 2008; 10: 1195–1203.

    CAS  Google Scholar 

  55. De Marinis L, Barbarino A . Calcium antagonists and hormone release. I. Effects of verapamil on insulin release in normal subjects and patients with islet-cell tumor. Metabolism 1980; 29: 599–604.

    Article  CAS  Google Scholar 

  56. Barbarino A, De Marinis L, Mancini A, Calabrò F, Massari M, D’Amico C et al. Calcium antagonists and hormone release. VI. Effects of a calcium antagonist (verapamil) on the biphasic insulin release in vivo. Diabetes Res 1988; 8: 21–24.

    CAS  PubMed  Google Scholar 

  57. Krempf M, Ranganatan S, Ritz P, Garnier JM, Charbonnel B . Effect of nifedipine on glucose potentiation of the acute insulin response to arginine in non-insulin-dependent diabetics. Eur J Clin Pharmacol 1991; 41: 411–415.

    Article  CAS  Google Scholar 

  58. Semple C, Thomson J, Beastall G, Lorimer A . Oral verapamil does not affect glucose tolerance in non-diabetics. Br J Clin Pharmacol 1983; 15: 570–571.

    Article  CAS  Google Scholar 

  59. Shamoon H, Baylor P, Kambosos D, Charlap S, Plawes S, Frishman WH . Influence of oral verapamil on glucoregulatory hormones in Man*. J Clin Endocrinol Metab 1985; 60: 536–541.

    Article  CAS  Google Scholar 

  60. Moreira RO, Moreira RBM, Machado NAM, Gonçalves TB, Coutinho WF . Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obes Surg 2008; 18: 1618–1621.

    Article  Google Scholar 

  61. Nath R, Johnson KW, Roessig JM, Ken D, Neale AC RM . XOMA 358, a novel treatment for hyperinsulinemic hypoglycemia: safety and clinical pharmacology from the first in human trial. Endocrine Rev 2015; 36 (Issue 2 Supplement).

  62. Johson K, Johnson KW, Gordon A, Neale AC, Vella A, Lee D et al. Single administration of Xoma 358, an insulin receptor attentuator improves post-meal and nighttime hypoglycemia profiles in post gastric bypass hypoglycemia (PGBH) patients. Endocrine Rev 2017; Vol 38 (Issue 2 Supplement).

  63. Castle JR, Engle JM, Youssef JE, Massoud RG, Yuen KCJ, Kagan R et al. Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care 2010; 33: 1282–1287.

    Article  CAS  Google Scholar 

  64. Mulla C . Automatec event-based system for the prevention of post-bariatric hypoglycemia using a mini-dose of a stable glucagon formulation. Endocrine Rev 2017; 38 (Issue 2 Supplement).

  65. Craig CM . Subcutaneous exendin 9-39 effectively treats post-bariatric hypoglycemia. Diabetes 2016; 65 (Issue Supplement 1).

  66. Mala T . Postprandial hyperinsulinemic hypoglycemia after gastric bypass surgical treatment. Surg Obes Relat Dis 2014; 10: 1220–1225.

    Article  Google Scholar 

  67. Spolverato G, Bhaijee F, Anders R, Salley K, Parambi J, Brown T et al. Total pancreatectomy for the management of refractory post-gastric bypass hypoglycemia. Dig Dis Sci 2015; 60: 1505–1509.

    Article  Google Scholar 

  68. McLaughlin T, Peck M, Holst J, Deacon C . Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clin Endocrinol Metab 2010; 95: 1851–1855.

    Article  CAS  Google Scholar 

  69. Z’graggen K, Guweidhi A, Steffen R, Potoczna N, Biral R, Walther F et al. Severe recurrent hypoglycemia after gastric bypass surgery. Obes Surg 2008; 18: 981–988.

    Article  Google Scholar 

  70. Vanderveen KA, Grant CS, Thompson GB, Farley DR, Richards ML, Vella A et al. Outcomes and quality of life after partial pancreatectomy for noninsulinoma pancreatogenous hypoglycemia from diffuse islet cell disease. Surgery 2010; 148: 1237–1246.

    Article  Google Scholar 

Download references

Acknowledgements

Marzieh Salehi is a scientific consultant with Eiger Pharm Co.; however, this has no effect on the materials presented. This work was supported by the National Institutes of Health grants: DK083554-05 (MS) and DK105379 (MS).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Yaqub.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yaqub, A., Smith, E. & Salehi, M. Hyperinsulinemic hypoglycemia after gastric bypass surgery: what’s up and what’s down?. Int J Obes 42, 286–294 (2018). https://doi.org/10.1038/ijo.2017.257

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2017.257

This article is cited by

Search

Quick links